Ghrelin and obestatin modulate early atherogenic processes on cells: enhancement of monocyte adhesion and oxidized low-density lipoprotein binding

Metabolism: Clinical and Experimental

Volumn 58, Issue 11, 2009, Pages 1572-1580

  Kellokoski, Eija ^a   Kunnari, Anne ^a   Jokela, Maarit ^a   Mäkelä, Sanna ^a   Kesäniemi, Y Antero ^a   Hörkkö, Sohvi ^a  

^a UNIVERSITY OF OULU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYL LOW DENSITY LIPOPROTEIN; CELL ADHESION MOLECULE; GHRELIN; GROWTH HORMONE SECRETAGOGUE RECEPTOR; INTERCELLULAR ADHESION MOLECULE 1; MONOCYTE CHEMOTACTIC PROTEIN 1; OBESTATIN; OXIDIZED LOW DENSITY LIPOPROTEIN; THIOGLYCOLIC ACID; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; ACETYL-LDL; LOW DENSITY LIPOPROTEIN;

ANIMAL CELL; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CELL CULTURE; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; LEUKOCYTE ADHERENCE; MACROPHAGE; MONOCYTE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OBESITY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ACYLATION; ANIMAL; BLOOD; C57BL MOUSE; CELL ADHESION; DRUG EFFECT; METABOLISM; OXIDATION REDUCTION REACTION; PATHOLOGY; PROTEIN BINDING;

ACYLATION; ANIMALS; ATHEROSCLEROSIS; CELL ADHESION; CELL ADHESION MOLECULES; CELLS, CULTURED; CHEMOKINE CCL2; ENDOTHELIAL CELLS; GHRELIN; HUMANS; LIPOPROTEINS, LDL; MACROPHAGES; MICE; MICE, INBRED C57BL; MONOCYTES; OXIDATION-REDUCTION; PROTEIN BINDING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 70449728066     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2009.05.009     Document Type: Article

References (49)

1. Kojima M., Hosoda H., Date Y., et al. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402 (1999) 656-660
2. Gnanapavan S., Kola B., Bustin S.A., et al. The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. J Clin Endocrinol Metab 87 (2002) 2988-2991
3. Kleinz M.J., Maguire J.J., Skepper J.N., et al. Functional and immunocytochemical evidence for a role of ghrelin and des-octanoyl ghrelin in the regulation of vascular tone in man. Cardiovasc Res 69 (2006) 227-235
4. Zhang J.V., Ren P.G., Avsian-Kretchmer O., et al. Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake. Science 310 (2005) 996-999
5. Hattori N. Expression, regulation and biological actions of growth hormone (GH) and ghrelin in the immune system. Growth Horm IGF Res (2009) [Electronic publication ahead of print]
6. St Pierre D.H., Bastard J.P., Coderre L., et al. Association of acylated ghrelin profiles with chronic inflammatory markers in overweight and obese postmenopausal women: a MONET study. Eur J Endocrinol 157 (2007) 419-426
7. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 340 (1999) 115-126
8. Pöykkö S.M., Kellokoski E., Ukkola O., et al. Plasma ghrelin concentrations are positively associated with carotid artery atherosclerosis in males. J Intern Med 260 (2006) 43-52
9. Bobryshev Y.V. Monocyte recruitment and foam cell formation in atherosclerosis. Micron 37 (2006) 208-222
10. Stoll G., and Bendszus M. Inflammation and atherosclerosis: novel insights into plaque formation and destabilization. Stroke 37 (2006) 1923-1932
11. Li W.G., Gavrila D., Liu X., et al. Ghrelin inhibits proinflammatory responses and nuclear factor-kappaB activation in human endothelial cells. Circulation 109 (2004) 2221-2226
12. Bowie A., and O'Neill L.A. Oxidative stress and nuclear factor-kappaB activation: a reassessment of the evidence in the light of recent discoveries. Biochem Pharmacol 59 (2000) 13-23
13. Skilton M.R., Nakhla S., Sieveking D.P., et al. Pathophysiological levels of the obesity related peptides resistin and ghrelin increase adhesion molecule expression on human vascular endothelial cells. Clin Exp Pharmacol Physiol 32 (2005) 839-844
14. Hannuksela M., Marcel Y.L., Kesäniemi Y.A., et al. Reduction in the concentration and activity of plasma cholesteryl ester transfer protein by alcohol. J Lipid Res 33 (1992) 737-744
15. Bird D.A., Gillotte K.L., Hörkkö S., et al. Receptors for oxidized low-density lipoprotein on elicited mouse peritoneal macrophages can recognize both the modified lipid moieties and the modified protein moieties: implications with respect to macrophage recognition of apoptotic cells. Proc Natl Acad Sci USA 96 (1999) 6347-6352
16. Habeeb A.F. Determination of free amino groups in proteins by trinitrobenzenesulfonic acid. Anal Biochem 14 (1966) 328-336
17. Hörkkö S., Bird D.A., Miller E., et al. Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins. J Clin Invest 103 (1999) 117-128
18. Basu S.K., Goldstein J.L., Anderson G.W., et al. Degradation of cationized low density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia fibroblasts. Proc Natl Acad Sci U S A 73 (1976) 3178-3182
19. Thornhill M.H., Li J., and Haskard D.O. Leucocyte endothelial cell adhesion: a study comparing human umbilical vein endothelial cells and the endothelial cell line EA-hy-926. Scand J Immunol 38 (1993) 279-286
20. Das U.N. Is metabolic syndrome X an inflammatory condition?. Exp Biol Med (Maywood) 227 (2002) 989-997
21. Suzuki H., Kurihara Y., Takeya M., et al. A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection. Nature 386 (1997) 292-296
22. Feigerlova E., Diene G., Conte-Auriol F., et al. Hyperghrelinemia precedes obesity in Prader-Willi syndrome. J Clin Endocrinol Metab 93 (2008) 2800-2805
23. Lamb A.S., and Johnson W.M. Premature coronary artery atherosclerosis in a patient with Prader-Willi syndrome. Am J Med Genet 28 (1987) 873-880
24. Page S.R., Nussey S.S., Haywood G.A., et al. Premature coronary artery disease and the Prader-Willi syndrome. Postgrad Med J 66 (1990) 232-234
25. Saran A.M., and DuBose Jr. T.D. Cardiovascular disease in chronic kidney disease. Ther Adv Cardiovasc Dis 2 (2008) 425-434
26. Garcia-Rubira J.C., Hidalgo R., Gomez-Barrado J.J., et al. Anorexia nervosa and myocardial infarction. Int J Cardiol 45 (1994) 138-140
27. Shiiya T., Nakazato M., Mizuta M., et al. Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion. J Clin Endocrinol Metab 87 (2002) 240-244
28. Sowers J.R. Obesity as a cardiovascular risk factor. Am J Med 115 Suppl 8A (2003) 37S-41S
29. Pöykkö S.M., Ukkola O., Kauma H., et al. Ghrelin Arg51Gln mutation is a risk factor for type 2 diabetes and hypertension in a random sample of middle-aged subjects. Diabetologia 46 (2003) 455-458
30. Kotani K., Sakane N., Saiga K., et al. Serum ghrelin and carotid atherosclerosis in older Japanese people with metabolic syndrome. Arch Med Res 37 (2006) 903-906
31. Genis B.B., Granada M.L., Alonso N., et al. Ghrelin, glucose homeostasis, and carotid intima media thickness in kidney transplantation. Transplantation 84 (2007) 1248-1254
32. Yano Y., Toshinai K., Inokuchi T., et al. Plasma des-acyl ghrelin, but not plasma HMW adiponectin, is a useful cardiometabolic marker for predicting atherosclerosis in elderly hypertensive patients. Atherosclerosis (2008)
33. Katugampola S.D., Pallikaros Z., and Davenport A.P. [125I-His(9)]-ghrelin, a novel radioligand for localizing GHS orphan receptors in human and rat tissue: up-regulation of receptors with atherosclerosis. Br J Pharmacol 134 (2001) 143-149
34. Baldanzi G., Filigheddu N., Cutrupi S., et al. Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT. J Cell Biol 159 (2002) 1029-1037
35. Gerrity R.G. The role of the monocyte in atherogenesis: I. Transition of blood-borne monocytes into foam cells in fatty lesions. Am J Pathol 103 (1981) 181-190
36. Takahashi K., Takeya M., and Sakashita N. Multifunctional roles of macrophages in the development and progression of atherosclerosis in humans and experimental animals. Med Electron Microsc 35 (2002) 179-203
37. Lieber M., Smith B., Szakal A., et al. A continuous tumor-cell line from a human lung carcinoma with properties of type II alveolar epithelial cells. Int J Cancer 17 (1976) 62-70
38. Bouis D., Hospers G.A., Meijer C., et al. Endothelium in vitro: a review of human vascular endothelial cell lines for blood vessel-related research. Angiogenesis 4 (2001) 91-102
39. Miller Y.I., Chang M.K., Binder C.J., et al. Oxidized low density lipoprotein and innate immune receptors. Curr Opin Lipidol 14 (2003) 437-445
40. Nicholson A.C., Frieda S., Pearce A., et al. Oxidized LDL binds to CD36 on human monocyte-derived macrophages and transfected cell lines. Evidence implicating the lipid moiety of the lipoprotein as the binding site. Arterioscler Thromb Vasc Biol 15 (1995) 269-275
41. Avallone R., Demers A., Rodrigue-Way A., et al. A growth hormone-releasing peptide that binds scavenger receptor CD36 and ghrelin receptor up-regulates sterol transporters and cholesterol efflux in macrophages through a peroxisome proliferator-activated receptor gamma-dependent pathway. Mol Endocrinol 20 (2006) 3165-3178
42. Torsello A., Bresciani E., Rossoni G., et al. Ghrelin plays a minor role in the physiological control of cardiac function in the rat. Endocrinology 144 (2003) 1787-1792
43. Hu C.Z., Cao Y.L., Huo H.Y., et al. Inhibitory effect of ghrelin on nicotine-induced VCAM-1 expression in human umbilical vein endothelial cells. J Cardiovasc Pharmacol 53 (2009) 241-245
44. Lyon C.J., Law R.E., and Hsueh W.A. Minireview: adiposity, inflammation, and atherogenesis. Endocrinology 144 (2003) 2195-2200
45. Dixit V.D., Schaffer E.M., Pyle R.S., et al. Ghrelin inhibits leptin- and activation-induced proinflammatory cytokine expression by human monocytes and T cells. J Clin Invest 114 (2004) 57-66
46. Xia Q., Pang W., Pan H., et al. Effects of ghrelin on the proliferation and secretion of splenic T lymphocytes in mice. Regul Pept 122 (2004) 173-178
47. Wu R., Dong W., Cui X., et al. Ghrelin down-regulates proinflammatory cytokines in sepsis through activation of the vagus nerve. Ann Surg 245 (2007) 480-486
48. Lauwers E., Landuyt B., Arckens L., et al. Obestatin does not activate orphan G protein-coupled receptor GPR39. Biochem Biophys Res Commun 351 (2006) 21-25
49. Tremblay F., Perreault M., Klaman L.D., et al. Normal food intake and body weight in mice lacking the G protein-coupled receptor GPR39. Endocrinology 148 (2007) 501-506